Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas.

Saved in:
Bibliographic Details
Title: Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas.
Authors: Su C; Department of Pharmacology and Cancer Biology and.; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Kent CL; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Pierpoint M; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Floyd W; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA., Luo L; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Williams NT; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Ma Y; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Peng B; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Lazarides AL; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Subramanian A; Department of Radiation Oncology, Stanford University, Stanford, California, USA., Himes JE; Department of Pharmacology and Cancer Biology and.; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Perez VM; Tempus AI Inc., Durham, North Carolina, USA., Hernansaiz-Ballesteros RD; Tempus AI Inc., Durham, North Carolina, USA., Roche KE; Tempus AI Inc., Durham, North Carolina, USA.; QuantBio LLC, Durham, North Carolina, USA., Modliszewski JL; QuantBio LLC, Durham, North Carolina, USA.; Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Selitsky SR; Tempus AI Inc., Durham, North Carolina, USA.; QuantBio LLC, Durham, North Carolina, USA., Shinohara ML; Department of Integrative Immunology.; Department of Molecular Genetics and Microbiology, and.; Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina, USA., Wisdom AJ; Harvard Radiation Oncology Program, Boston, Massachusetts, USA., Moding EJ; Department of Radiation Oncology, Stanford University, Stanford, California, USA.; Stanford Cancer Institute, Stanford University, Stanford, California, USA., Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Kirsch DG; Department of Pharmacology and Cancer Biology and.; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Radiation Oncology and.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Source: JCI insight [JCI Insight] 2024 Jun 13; Vol. 9 (14). Date of Electronic Publication: 2024 Jun 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.178767